UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unifying Family A GPCR Theories of Activation

Pharmacology & therapeutics (Oxford), 2014-07, Vol.143 (1), p.51-60

2014

Volltextzugriff (PDF)

Crystal Structure of Human Cytochrome P450 2D6

The Journal of biological chemistry, 2006-03, Vol.281 (11), p.7614-7622

2006

Volltextzugriff (PDF)

Definition of the G Protein-Coupled Receptor Transmembrane Bundle Binding Pocket and Calculation of Receptor Similarities for Drug Design

Journal of medicinal chemistry, 2009-07, Vol.52 (14), p.4429-4442

2009

Volltextzugriff (PDF)

Differences in the Central Nervous System Distribution and Pharmacology of the Mouse 5-Hydroxytryptamine-6 Receptor Compared with Rat and Human Receptors Investigated by Radioligand Binding, Site-Directed Mutagenesis, and Molecular Modeling

Molecular pharmacology, 2003-12, Vol.64 (6), p.1295-1308

2003

Volltextzugriff (PDF)

2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic Acid (PD-307243) Causes Instantaneous Current through Human Ether-a-go-go-Related Gene Potassium Channels

Molecular pharmacology, 2008-03, Vol.73 (3), p.639-651

2008

Volltextzugriff (PDF)

G-protein-coupled receptor dynamics: dimerization and activation models compared with experiment

Biochemical Society transactions, 2012-04, Vol.40 (2), p.394-399

2012

Volltextzugriff (PDF)

CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach

Journal of medicinal chemistry, 2003-09, Vol.46 (19), p.4070-4086

2003

Volltextzugriff (PDF)

Structural Determinants of Drugs Acting on the Nav1.8 Channel

The Journal of biological chemistry, 2009-04, Vol.284 (16), p.10523-10536

2009

Volltextzugriff (PDF)

Functional analysis of CYP2D6.31 variant: Homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution

Proteins, structure, function, and bioinformatics, 2005-05, Vol.59 (2), p.339-346

2005

Volltextzugriff (PDF)

Modeling GPCR active state conformations: the β(2)-adrenergic receptor

Proteins, structure, function, and bioinformatics, 2011-05, Vol.79 (5), p.1441

2011

Volltextzugriff (PDF)

1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3 Receptor Antagonists

Journal of medicinal chemistry, 2010-01, Vol.53 (1), p.374-391

2010

Volltextzugriff (PDF)

1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D3 Receptor Antagonists

Journal of medicinal chemistry, 2007-10, Vol.50 (21), p.5076-5089

2007

Volltextzugriff (PDF)

Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor

Journal of medicinal chemistry, 1991-09, Vol.34 (9), p.2726-2735

1991

Volltextzugriff (PDF)

6-Chloro-5-methyl-1-[[2-[(2-methyl-3- pyridyl)oxy]-5-pyridyl]carbamoyl]indoline (SB-242084): The First Selective and Brain Penetrant 5-HT2C Receptor Antagonist

Journal of medicinal chemistry, 1997-10, Vol.40 (22), p.3494-3496

1997

Volltextzugriff (PDF)

Modeling GPCR active state conformations: The β2-adrenergic receptor

Proteins, structure, function, and bioinformatics, 2011-05, Vol.79 (5), p.1441-1457

2011

Volltextzugriff (PDF)

Synthesis and Pharmacological Characterization of Novel Druglike Corticotropin-Releasing Factor 1 Antagonists

Journal of medicinal chemistry, 2008-12, Vol.51 (23), p.7370-7379

2008

Volltextzugriff (PDF)

Discovery of Novel 1-Azoniabicyclo[2.2.2]octane Muscarinic Acetylcholine Receptor Antagonists

Journal of medicinal chemistry, 2009-04, Vol.52 (8), p.2493-2505

2009

Volltextzugriff (PDF)

Novel 5-HT1A/1B/1D receptors antagonists with potent 5-HT reuptake inhibitory activity

Bioorganic & medicinal chemistry letters, 2008-10, Vol.18 (20), p.5581-5585

2008

Volltextzugriff (PDF)

Design, Synthesis, and Structure−Activity Relationship of Tropane Muscarinic Acetylcholine Receptor Antagonists

Journal of medicinal chemistry, 2009-08, Vol.52 (16), p.5241-5252

2009

Volltextzugriff (PDF)

Dihydropyrrole[2,3-d]pyridine Derivatives as Novel Corticotropin-Releasing Factor-1 Antagonists: Mapping of the Receptor Binding Pocket by in Silico Docking Studies

Journal of medicinal chemistry, 2008-11, Vol.51 (22), p.7273-7286

2008

Volltextzugriff (PDF)

Modeling the pore structure of voltage-gated sodium channels in closed, open, and fast-inactivated conformation reveals details of site 1 toxin and local anesthetic binding

Journal of molecular modeling, 2006-09, Vol.12 (6), p.813-822

2006

Volltextzugriff (PDF)

Approaches to the Molecular Modeling of 7‐Transmembrane Helical Receptors

Current Protocols in Pharmacology, 2006-12, Vol.35 (1), p.9.8.1-9.8.41

Blaney, Frank E.

2006

Volltextzugriff (PDF)

3,4 -Dihydro -2H -benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (4), p.1033-1036

2007

Volltextzugriff (PDF)

Stepwise Modulation of Neurokinin-3 and Neurokinin-2 Receptor Affinity and Selectivity in Quinoline Tachykinin Receptor Antagonists

Journal of medicinal chemistry, 2001-05, Vol.44 (11), p.1675-1689

2001

Volltextzugriff (PDF)

Modeling Active GPCR Conformations

Methods in Enzymology, 2013, Vol.522, p.21-35

2013

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(79)
Buchkapitel
(4)

Sprache

Englisch
(83)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(47)
Humans
(38)
Animals
(30)
Biological And Medical Sciences
(28)
Medical Sciences
(27)
Male
(22)
Pharmacology & Pharmacy
(22)
Pharmacology. Drug Treatments
(22)
Models, Molecular
(18)
Chemistry, Medicinal
(15)
Oncology
(14)
Rats
(13)
Neuropharmacology
(12)
Biochemistry & Molecular Biology
(11)
Structure-Activity Relationship
(11)
Binding Sites
(10)
Neurotransmitters. Neurotransmission. Receptors
(10)
Cho Cells
(9)
Cricetinae
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Unifying Family A GPCR Theories of Activation

Crystal Structure of Human Cytochrome P450 2D6

Definition of the G Protein-Coupled Receptor Transmembrane Bundle Binding Pocket and Calculation of Receptor Similarities for Drug Design

Differences in the Central Nervous System Distribution and Pharmacology of the Mouse 5-Hydroxytryptamine-6 Receptor Compared with Rat and Human Receptors Investigated by Radioligand Binding, Site-Directed Mutagenesis, and Molecular Modeling

2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic Acid (PD-307243) Causes Instantaneous Current through Human Ether-a-go-go-Related Gene Potassium Channels

G-protein-coupled receptor dynamics: dimerization and activation models compared with experiment

CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach

Structural Determinants of Drugs Acting on the Nav1.8 Channel

Functional analysis of CYP2D6.31 variant: Homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution

Modeling GPCR active state conformations: the β(2)-adrenergic receptor

1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3 Receptor Antagonists

1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D3 Receptor Antagonists

Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor

6-Chloro-5-methyl-1-[[2-[(2-methyl-3- pyridyl)oxy]-5-pyridyl]carbamoyl]indoline (SB-242084): The First Selective and Brain Penetrant 5-HT2C Receptor Antagonist

Modeling GPCR active state conformations: The β2-adrenergic receptor

Synthesis and Pharmacological Characterization of Novel Druglike Corticotropin-Releasing Factor 1 Antagonists

Discovery of Novel 1-Azoniabicyclo[2.2.2]octane Muscarinic Acetylcholine Receptor Antagonists

Novel 5-HT1A/1B/1D receptors antagonists with potent 5-HT reuptake inhibitory activity

Design, Synthesis, and Structure−Activity Relationship of Tropane Muscarinic Acetylcholine Receptor Antagonists

Dihydropyrrole[2,3-d]pyridine Derivatives as Novel Corticotropin-Releasing Factor-1 Antagonists: Mapping of the Receptor Binding Pocket by in Silico Docking Studies

Modeling the pore structure of voltage-gated sodium channels in closed, open, and fast-inactivated conformation reveals details of site 1 toxin and local anesthetic binding

Approaches to the Molecular Modeling of 7‐Transmembrane Helical Receptors

3,4 -Dihydro -2H -benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors

Stepwise Modulation of Neurokinin-3 and Neurokinin-2 Receptor Affinity and Selectivity in Quinoline Tachykinin Receptor Antagonists

Modeling Active GPCR Conformations

Suchergebnisse filtern